Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
International Journal of Cardiology. Heart & Vasculature
|
October 16, 2024
Recent highlights from the <i>International Journal of Cardiology Heart and Vasculature</i>: Spatiotemporal and functional immunoprofiling and its theranostic potential
Florian Bruns, Dobromir Dobrev, Anke C Fender
International Journal of Cardiology. Heart & Vasculature
|
November 10, 2025
Factor XIII and cardiovascular disease: biomarker, culprit or victim in acute myocardial infarction outcomes?
Florian Bruns, Dobromir Dobrev, Anke C Fender
International Journal of Cardiology
|
January 24, 2025
Sex and atrial fibrillation-associated risk estimation and management
Anke C Fender, Florian Bruns, Dobromir Dobrev
Pharmacological Research
|
May 6, 2019
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants
Anke C Fender, Reza Wakili, Dobromir Dobrev
International Journal of Cardiology. Heart & Vasculature
|
May 22, 2019
Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
Reza Wakili, Lisa Riesinger, Anke C Fender, et al.
Cardiovascular Research
|
July 9, 2018
Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter?
Dobromir Dobrev, Anke C Fender, Xander H T Wehrens
Thrombosis and Haemostasis
|
October 19, 2017
Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
Anke C Fender, Bernhard H Rauch, Tobias Geisler, et al.
International Journal of Cardiology
|
December 19, 2017
Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose: PAR-4 in cardiac fibroblasts
Sonja Kleeschulte, Johann Jerrentrup, Daniel Gorski, et al.
Cardiovascular Research
|
November 26, 2025
Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications
Florian Bruns, Anke C Fender, Theresa Poppenborg, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 2, 2014
Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes
Anke C Fender, Goran Pavic, Grant R Drummond, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
International Journal of Cardiology. Heart & Vasculature
|
October 16, 2024
Recent highlights from the <i>International Journal of Cardiology Heart and Vasculature</i>: Spatiotemporal and functional immunoprofiling and its theranostic potential
Florian Bruns, Dobromir Dobrev, Anke C Fender
International Journal of Cardiology. Heart & Vasculature
|
November 10, 2025
Factor XIII and cardiovascular disease: biomarker, culprit or victim in acute myocardial infarction outcomes?
Florian Bruns, Dobromir Dobrev, Anke C Fender
International Journal of Cardiology
|
January 24, 2025
Sex and atrial fibrillation-associated risk estimation and management
Anke C Fender, Florian Bruns, Dobromir Dobrev
Pharmacological Research
|
May 6, 2019
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants
Anke C Fender, Reza Wakili, Dobromir Dobrev
International Journal of Cardiology. Heart & Vasculature
|
May 22, 2019
Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
Reza Wakili, Lisa Riesinger, Anke C Fender, et al.
Cardiovascular Research
|
July 9, 2018
Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter?
Dobromir Dobrev, Anke C Fender, Xander H T Wehrens
Thrombosis and Haemostasis
|
October 19, 2017
Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
Anke C Fender, Bernhard H Rauch, Tobias Geisler, et al.
International Journal of Cardiology
|
December 19, 2017
Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose: PAR-4 in cardiac fibroblasts
Sonja Kleeschulte, Johann Jerrentrup, Daniel Gorski, et al.
Cardiovascular Research
|
November 26, 2025
Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications
Florian Bruns, Anke C Fender, Theresa Poppenborg, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 2, 2014
Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes
Anke C Fender, Goran Pavic, Grant R Drummond, et al.
Page
of 8